Jérôme Biton

机构：Inserm, Sorbonne Université, Université Sorbonne Paris Nord · ORCID：0000-0002-4720-4567

发表论文 59 篇 · 总被引 3242 次 · h-index 24

代表论文

• Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment (2018 · Proceedings of the National Academy of Sciences · 被引 948)
• TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma (2018 · Clinical Cancer Research · 被引 366)
• The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort (2019 · Journal of Translational Medicine · 被引 151)
• Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors (2019 · Journal of Thoracic Oncology · 被引 96)
• Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients (2021 · Frontiers in Immunology · 被引 83)
• SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils (2022 · Lung Cancer · 被引 49)